ISRG vs NKE: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and NIKE, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Intuitive Surgical, Inc. · Healthcare
$399.52
+22.4% upside to fair value
Med Conviction
Grade B
High Quality
VS
NIKE, Inc. · Consumer Cyclical
$35.78
+9.9% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
ISRG has more upside to fair value
(+22.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
NKE |
| Current Price |
$399.52 |
$35.78 |
| Fair Value Estimate |
$488.97 |
$39.33 |
| Upside to Fair Value |
+22.4%
|
+9.9%
|
| Market Cap |
$141.1B |
$53.0B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
30.7x
|
12.0x
|
| Price / Sales |
12.8x
|
1.1x
|
| Price / FCF |
44.0x
|
24.3x
|
| Revenue Growth YoY |
+18.5%
|
-1.1%
|
| Gross Margin |
66.7%
|
42.9%
|
| Operating Margin |
31.3%
|
8.2%
|
| Return on Equity |
17.8%
|
22.0%
|
| Dividend Yield |
0% |
4.58% |
| FCF Yield |
2.28%
|
4.12%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Intuitive Surgical develops, produces, and commercializes the da Vinci surgical system and the Ion endoluminal system, along with instruments, accessories, training, and digital solutions that drive a large installed-base and recurring-revenue model. Business quality is high: TTM gross margin of 66.7%, operating margin of 31.3%, net margin of 28.4%, ROE of 17.8%, and revenue growth of 18.5% with …
NIKE designs, markets and distributes athletic footwear, apparel and equipment through the Nike, Jordan and Converse brands, supported by global athlete marketing, valuable intellectual property and a broad wholesale and owned-digital network. Business quality is medium: its brand moat and 22.0% ROE remain meaningful, but the moat is narrowing amid intense competition, weak direct sales and uneve…
Accumulation Zones
| Metric |
ISRG |
NKE |
| Zone Low |
$366.73 |
$29.50 |
| Zone High |
$415.62 |
$33.43 |
| In Buy Zone? |
Yes
|
No
|